Electronic prescribing Medicare bonus in '09
March 1st 2009Physicians can receive a 2% bonus for e-prescribing and participating in the Physician's Quality Reporting Initiative, adding up to a potential 4% bonus to participating doctors in 2009. This year, program participation is not mandatory, but in 2012, physicians will be penalized –1% for not e-prescribing.
Recovery audit contractor's focus on low-hanging fruit may turn to specialties
March 1st 2009Federal regulators have judged the first phase of the Medicare Recovery Audit Contractor (RAC) program a success, but the controversial plan promises potential headaches for physicians as it goes forward. In response to the initial success, the Centers for Medicare & Medicaid Services announced in October its plan to expand the program to a dozen new states in the first quarter of 2009. By January 2010, all 50 states will be in RAC's crosshairs.
Post-LASIK ectasia is not only increased by central corneal thickness
March 1st 2009No existing scientific evidence validates the presumption that thinner preoperative corneal thickness independently increases the risk of post-LASIK ectasia, as long as intraoperative pachymetry is performed to guard against a thicker-than-expected flap. In fact, thin corneas in eyes with normal topography appear to be biomechanically strong. Routine preoperative topographic screening should be performed to detect abnormalities that suggest an increased risk for post-LASIK ectasia.
Optimized, customized wavefront LASIK equal
March 1st 2009Results obtained with wavefront-optimized LASIK are equivalent to those achieved with wavefront-customized LASIK, according to a retrospective study of 148 patients. The wavefront-optimized approach also presents an option for the approximately one-third of patients who cannot undergo customized treatment for one of several reasons, according to the ophthalmologist who conducted the research.
Difluprednate is noninferior to prednisolone, data show
March 1st 2009Difluprednate ophthalmic emulsion 0.05% (Durezol, Sirion Therapeutics) was comparable with prednisolone ophthalmic suspension 1% (Pred Forte, Allergan), the current standard of care, in a pivotal anterior uveitis trial. Difluprednate was dosed four times daily compared with eight times for prednisolone acetate, suggesting that it could enhance compliance.
Capsulorhexis tear-out salvaged by simple maneuver
March 1st 2009When capsulorrhexis becomes complicated by a radial tear, pulling the flap backward, first circumferentially and then centrally, can rescue the tear-out. Here, an ophthalmologist shares a technique to successfully address this complication.
IOP-lowering benefits of cataract surgery more significant than previously realized
March 1st 2009Cataract surgery can dramatically lower elevated IOP, and the effect appears to be quite durable. This benefit, together with the safety of phacoemulsification, suggests that ophthalmologists should consider its role as a stand-alone procedure to treat co-morbid cataract and glaucoma.
Cultural flair of San Francisco is unmatched worldwide
March 1st 2009San Francisco is nearly synonymous with a high cost of living. The advent and financial success of the early years of the Internet revolution still lures high-income folks to the city by the bay. Property values and household income are among the top in the nation, which enables a profitable restaurant and entertainment scene.
For dry eye patients punctal plugs offer flow control
March 1st 2009Soft Plug Flow Control Silicone Plugs (Oasis Medical) provide partial occlusion of the puncta with limited tear drainage for patients with moderate and severe dry eye. These plugs eliminate epiphora in patients for whom total occlusion is excessive.
Corneal topography stability after crosslinking is demonstrated by comprehensive analyses
March 1st 2009Results from visual acuity testing, refraction, and corneal topography analysis using Scheimpflug imaging (Pentacam, Oculus) in a series of 48 eyes with progressive keratoconus demonstrate the benefits of corneal collagen crosslinking for halting keratoconus progression. More research is needed to provide answers to questions about the long-term stability of collagen corneal crosslinking and to refine its indications and contraindications.
Eye-care position receives new classification
March 1st 2009The Joint Commission on Allied Health Personnel in Ophthalmology announced in a prepared statement that it has received approval for a separate occupational classification, ophthalmic medical technician, from the U.S. Bureau of Labor's 2010 Standard Occupational Classification committee.
Dyax, Fovea enter into license agreement
March 1st 2009Dyax Corp. and Fovea Pharmaceuticals have entered into an exclusive license agreement for the development and commercialization of an ocular formulation of DX-88 for the treatment of retinal diseases, the companies announced in a joint statement.
Roche attempts hostile takeover
March 1st 2009Analysts and ophthalmologists are closely watching the drama unfolding between private Swiss drugmaker Roche and the publicly traded, California-based Genentech, maker of ranibizumab (Lucentis), the only FDA-approved treatment for age-related macular degeneration (AMD), and its popular cousin, bevacizumab (Avastin). Roche is attempting a hostile takeover of Genentech.
Implementing an electronic prescribing system
February 27th 2009This is the personal experience of electronic prescribing (e-prescribing) implementation presented by Cindy Maddox, MD, FACS, director of glaucoma services and vice chairwoman at the New England Eye Center, Tufts University School of Medicine, Boston and member of the American Academy of Ophthalmology's health policy committee.
People with astigmatism are unaware of contact lens options, says survey
February 24th 2009A survey conducted by independent research firm, Decision Analyst, and sponsored by Bausch & Lomb, found that four out of 10 consumers incorrectly believe that their astigmatism prevents them from wearing contact lenses.
Mumbai Eye Care Campaign launched to prevent blindness
February 24th 2009Sightsavers International has launched the Mumbai Eye Care Campaign to prevent avoidable blindness and to offer eye care to millions of Mumbai's citizens in underserved areas of the city, such as Dharavi, the setting of the award-winning film, 'Slumdog Millionaire.'